-
Pulmonary Sarcoidosis Pipeline Insights, Clinical Trials Assessment, Emerging Therapies and Companies | DelveInsight
22 Jan 2025 10:05 GMT
… companies with DelveInsight @ Pulmonary Sarcoidosis Treatment Drugs
Pulmonary Sarcoidosis Emerging Drugs
• CMK … report now! @ New Pulmonary Sarcoidosis Drugs
Pulmonary Sarcoidosis Companies
Novartis, aTyr Pharma …
-
Foundation for Sarcoidosis Research Warns of Increased Risk of Sarcoidosis from Fire and Smoke Exposure Urging Immediate Action to Prevent Future Health Consequences
16 Jan 2025 23:43 GMT
… more about sarcoidosis, visit stopsarcoidosis.org. About Sarcoidosis Sarcoidosis is a … Despite advances in research, sarcoidosis remains challenging to diagnose, with … the Foundation for Sarcoidosis Research The Foundation for Sarcoidosis Research (FSR) …
-
Assessment of Disease Modifying Antirheumatic Drugs in Cardiac Sarcoidosis Treatment
08 Jan 2025 16:24 GMT
… methotrexate, mycophenolate, or azathioprine for sarcoidosis. Hazard ratios (HR) were … patients with cardiac sarcoidosis and preventing cardiac sarcoidosis in patients with … mofetil for patients with sarcoidosis or cardiac sarcoidosis.
Source: academic.oup …
-
Fewer than 50% of patients with sarcoidosis treated within year of diagnosis
03 Jan 2025 14:28 GMT
… treatment of patients with sarcoidosis, particularly in relation … the likelihood for sarcoidosis treatment in this … and increased adjusted odds for sarcoidosis treatment:
hypercalcemia (adjusted …
“Treatment decisions in sarcoidosis can be complicated with …
-
Cardiac Sarcoidosis: Diagnostic Tips for Clinicians
17 Dec 2024 14:22 GMT
… related to sarcoidosis and cardiac sarcoidosis.
Suspecting Cardiac Sarcoidosis: What Are … the Red Flags?
First, sarcoidosis … classic features of cardiac sarcoidosis include multifocal uptake, particularly …
-
Study reveals variation in sarcoidosis treatment approaches across patients Sa...
11 Dec 2024 03:11 GMT
… failure. While some patients with sarcoidosis have spontaneous disease remission, … real-world practice patterns of sarcoidosis treatment have been incomplete.
In … assessed whether patients diagnosed with sarcoidosis received either corticosteroids or …
-
aTyr Pharma Announces Third Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
10 Dec 2024 13:00 GMT
… in patients with pulmonary sarcoidosis. The DSMB recommended that … condition such as pulmonary sarcoidosis, where reducing or replacing … 268 subjects with pulmonary sarcoidosis at multiple centers … of lung function and sarcoidosis symptoms. More information …
-
Kinevant Sciences Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis
03 Dec 2024 12:00 GMT
… participants with chronic active pulmonary sarcoidosis. Primary Endpoint Details: … self-reported breathlessness. About Sarcoidosis Pulmonary sarcoidosis is a lung disease … second-line therapies respectively for sarcoidosis; however, these therapeutic …
-
Roivant Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis
03 Dec 2024 12:00 GMT
… participants with chronic active pulmonary sarcoidosis. Primary Endpoint Details: … self-reported breathlessness. About Sarcoidosis Pulmonary sarcoidosis is a lung disease … second-line therapies respectively for sarcoidosis; however, these therapeutic …
-
A Case for Expanding the Differential Diagnosis of Cardiac Sarcoidosis
02 Dec 2024 23:01 GMT
… atrioventricular block.
“Clinically significant cardiac sarcoidosis (CS) is estimated to be … a potentially fatal presentation of sarcoidosis, the researchers noted.
Dr. … an interdisciplinary evaluation for presumed sarcoidosis with CS.
This patient presented …